期刊文献+

纳米靶向给药系统与口腔癌治疗 被引量:3

Nano targeted drug delivery system and the treatment of oral cancer
原文传递
导出
摘要 口腔癌是头颈部较常见的恶性肿瘤之一,被动靶向是口腔癌最初的靶向治疗,靶向性差.为了更好地实现对口腔癌靶向治疗,近年来学者们转向于研究主动靶向纳米给药系统,即将靶分子连接在纳米粒表面,使其与肿瘤细胞表面特异性表达或者过度表达的某种受体结合而实现靶向,该靶向系统可将抗肿瘤药物定向输送于病变部位,达到降低不良反应、增加疗效的目的.靶向性化疗已成为口腔癌治疗的趋势. Oral cancer is one of the most common malignant tumor of the head and neck. Passive tar- geting is a targeted therapy for initial treatment of oral cancer, which is not always effective. In order to achieve better targeted therapy on oral cancer, researchers have turned to the study of active targeting with nano drug delivery system in recent years. With this treatment, nanoparticles are attached to the surface of the target mole- cules, and combine with specific expression or overexpression receptor on the surface of tumor cell to achieve target. This delivery system can transport anticaneer drugs directed at the lesion site and achieve the purpose of reducing adverse drug reaction and increasing treatment efficacy. Targeted chemotherapy is increasing being used in the treatment of oral cancer.
作者 马萍 金武龙
出处 《国际肿瘤学杂志》 CAS 2014年第10期753-756,共4页 Journal of International Oncology
关键词 纳米技术 药物疗法 口腔肿瘤 药物释放系统 Nanotechnology Drug therapy Mouth neoplasms Drug delivery systems
  • 相关文献

参考文献25

  • 1Tran PH,Tran TT,Vo TV,et al.Novel multifunctional biocompati ble gelatin-oleic acid conjugate:self-assembled nanoparticles for drug delivery[J].J Biomed Nanotechnol,2013,9(8):1416-1431.
  • 2Augustin MA,Sanguansri L,Lockett T.Nano-and micro-encapsulated systems for enhancing the delivery of resveratrol[J].Ann NY Acad Sci,2013,1290:107-112.
  • 3Snehalatha M,Kolachina V,Saha RN,et al.Enhanced tumor uptake,biodistribution and pharmacokinetics of etoposide loaded nanoparticles in Dalton's lymphoma tumor bearing mice[J].J Pharm Bioallied Sci,2013,5(4):290-297.
  • 4Yang T,Sheng HH,Feng NP,et al.Preparation of andrographolideloaded solid lipid nanoparticles and their in vitro and in vivo evaluations:characteristics,release,absorption,transports,pharmacokinetics,and antihyperlipidemic activity[J].J Pharm Sci,2013,102(12):4414-4425.
  • 5Afifi MM,Austin LA,Mackey MA,et al.XAV939:from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticles[J].Bioconjug Chem,2014,25(2):207-215.
  • 6Yuan F,Dellian M,Fukumura D,et al.Vascular permeability in a human tumor xenograft:molecular size dependence and cutoff size[J].Cancer Res,1995,55(17):3752-3756.
  • 7孟淑静,曹春蕊,任艳焕,马冬雪.血管通透性及其相关因素研究进展[J].实用心脑肺血管病杂志,2011,19(10):1814-1815. 被引量:13
  • 8Duncan R,Sat-Klopsch YN,Burger AM,et al.Validation of tumour models for use in anticancer nanomedicine evaluation:the EPR effect and cathepsin B-mediated drug release rate[J].Cancer Chemother Pharmacol,2013,72(2):417-427.
  • 9Maeda H,Bharate GY,Daruwalla J.Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect[J].Eur J Pharm Biopharm,2009,71(3):409-419.
  • 10于莲,崔丹,应晓英,杜永忠.表面修饰脂质纳米粒给药系统的研究进展[J].中国现代应用药学,2011,28(2):108-112. 被引量:14

二级参考文献74

共引文献55

同被引文献38

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部